US STOCK
BBIO Stock Analysis
US stocks · market data · technical indicators
BridgeBio Pharma, Inc.
BBIOUS stocksQuote delayed 15 min
10/27 下午06:08 updated
$68.15
-0.41-0.60%
Open
$68.56
High
$68.83
Low
$67.87
Volume
205.92萬
BBIO price history
+2.31%Open
66.61
Latest
68.15
High
68.56
Low
63.30
Average
66.58
Advertisement
Financial snapshot
BBIO - BridgeBio Pharma, Inc.
EPS
-3.56USD
Forward EPS
-0.22USD
P/E
--
Forward P/E
-303.40x
P/B
-5.29x
ROE
--
ROA
-26.00%
Operating margin
-43.94%
Profit margin
-97.03%
Revenue growth
120.40%
Earnings growth
--
Dividend yield
0.00%
Financial statements
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| Revenue | $243.68M | $194.51M | $154.18M | $120.70M | $110.56M |
| Gross profit | $228.63M | $184.58M | $146.07M | $114.14M | $106.91M |
| Operating income | -$107.08M | -$105.96M | -$128.43M | -$136.36M | -$133.47M |
| Net income | -$152.22M | -$164.04M | -$192.86M | -$182.74M | -$181.90M |
| Basic EPS | -0.78 | -0.84 | -1.00 | -0.95 | -0.95 |
| Diluted EPS | -0.78 | -0.84 | -1.00 | -0.95 | -0.95 |
Estimates vs actuals
Next earnings
2026-10-29
EPS estimate
-0.56
Revenue estimate
$295.75M
Last surprise
-33.87%
| Date | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-10-29 | -0.56 | Not reported | — |
| 2026-08-10 | -0.58 | -0.78 | -33.87% |
| 2026-05-07 | -0.62 | -0.84 | -36.22% |
| 2026-02-24 | -0.62 | -0.94 | -50.63% |
| 2025-10-29 | -0.78 | -0.72 | +7.73% |
| 2025-08-05 | -0.60 | -0.95 | -57.12% |
| 2025-04-29 | -1.00 | -0.99 | +0.87% |
| 2025-02-20 | -1.09 | -1.37 | -26.09% |
| 2024-11-12 | -0.86 | -1.08 | -25.14% |
| 2024-08-01 | -0.94 | -1.01 | -7.24% |
| 2024-05-02 | -0.54 | -0.12 | +77.01% |
| 2024-02-22 | -0.80 | -0.96 | -20.13% |
Institutional holders
| Institution | Quarter | Value held | Portfolio weight |
|---|---|---|---|
| VANGUARD GROUP INC | 2025-12-31 | $1.3B | 0.02% |
| TWO SIGMA INVESTMENTS, LP | 2026-06-30 | $351.7M | 0.25% |
| STATE STREET CORP | 2026-06-30 | $330.4M | 0.01% |
| BlackRock Inc. | 2024-06-30 | $315.3M | 0.01% |
| CITADEL ADVISORS LLC | 2026-06-30 | $280M | 0.03% |
| RENAISSANCE TECHNOLOGIES LLC | 2026-06-30 | $63.8M | 0.09% |
| Bridgewater Associates, LP | 2026-06-30 | $33.4M | 0.14% |
13F quarterly filings. Reporting periods differ by institution; value and weight reflect each institution's own latest quarter.
Analyst ratings
Mean target
$107.81
Target range
$80.00 – $156.00
Implied upside
58.19%
Strong buy
6
Buy
15
Hold
2
Sell
0
Strong sell
0
Advertisement